ASKBIO Trademark

Trademark Overview

On Wednesday, May 31, 2023, a trademark application was filed for ASKBIO with the United States Patent and Trademark Office. The USPTO has given the ASKBIO trademark a serial number of 98975825. The federal status of this trademark filing is REGISTERED as of Tuesday, May 13, 2025. This trademark is owned by Asklepios BioPharmaceutical, Inc.. The ASKBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creating DNA extracts; scientific and technological services, namely, scientific research, analysis, design and development in the field of DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; scientific consultancy services in the fields of gene therapy, diagnostics, agri-biotechnology, nano technology and DNA analysis
askbio

General Information

Serial Number98975825
Word MarkASKBIO
Filing DateWednesday, May 31, 2023
Status700 - REGISTERED
Status DateTuesday, May 13, 2025
Registration Number7795568
Registration DateTuesday, May 13, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2024

Trademark Statements

Pseudo MarkASK BIO
Goods and ServicesScientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creating DNA extracts; scientific and technological services, namely, scientific research, analysis, design and development in the field of DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; scientific consultancy services in the fields of gene therapy, diagnostics, agri-biotechnology, nano technology and DNA analysis
Certificate of Correction for RegistrationIn the Statement, line 1, "NORTH CAROLINA" should be deleted, and, "DELAWARE" should be inserted. 

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 2, 2023
Primary Code042
First Use Anywhere DateFriday, September 24, 2004
First Use In Commerce DateFriday, September 24, 2004

Trademark Owner History

Party NameAsklepios BioPharmaceutical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
US
Party NameAsklepios BioPharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
US
Party NameAsklepios BioPharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
US

Trademark Events

Event DateEvent Description
Saturday, June 3, 2023NEW APPLICATION ENTERED
Sunday, July 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 2, 2024ASSIGNED TO EXAMINER
Friday, February 9, 2024NON-FINAL ACTION WRITTEN
Friday, February 9, 2024NON-FINAL ACTION E-MAILED
Friday, February 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 7, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 7, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, February 10, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 18, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 5, 2024DIVISIONAL REQUEST RECEIVED
Thursday, April 24, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, November 5, 2024NOTICE OF ALLOWANCE CANCELLED
Thursday, April 24, 20251(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 13, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 13, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 1, 2025TEAS SECTION 7 REQUEST RECEIVED
Saturday, December 27, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, December 27, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, January 20, 2026NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Wednesday, March 25, 2026CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, April 14, 2026NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

askbio research scientific field development services analysis fields diagnostics technological biotechnology